{"entity":{"id":"cheng-ying","kind":"person","name":"Ying Cheng","aka":["程颖"],"tldr":"Ying Cheng has led most of the Chinese small cell lung cancer immunotherapy trials, including ASTRUM-005 and CAPSTONE-1.","summary":"Principal investigator of ASTRUM-005 (serplulimab plus chemotherapy, JAMA 2022), CAPSTONE-1 (adebrelimab plus chemotherapy, Lancet Oncology 2022) and the benmelstobart plus anlotinib trial in extensive-stage SCLC, as well as Chinese cohorts of global lung cancer studies; chairs CSCO's small cell lung cancer committee.","asOf":"2026-09-10","links":[{"label":"Jilin Cancer Hospital","url":"https://www.jlszlyy.com/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Cheng%20Y%5BAuthor%5D%20small%20cell%20lung%20cancer%20Jilin%20Cancer%20Hospital"}],"tags":["china"],"related":[],"cancers":["sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["serplulimab","adebrelimab","anlotinib"],"companies":[],"institutions":["jilin-cancer-hospital"],"pathways":[],"terms":[],"trials":["astrum-005","capstone-1"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Professor and President, Jilin Cancer Hospital, Changchun","institutionId":"jilin-cancer-hospital","specialisms":["Small cell lung cancer","Thoracic oncology","Immunotherapy trials"],"profiles":[{"label":"Jilin Cancer Hospital","url":"https://www.jlszlyy.com/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Cheng%20Y%5BAuthor%5D%20small%20cell%20lung%20cancer%20Jilin%20Cancer%20Hospital"}],"papers":[{"title":"Effect of first-line serplulimab vs placebo added to chemotherapy on survival in patients with extensive-stage small cell lung cancer: the ASTRUM-005 randomized clinical trial","journal":"JAMA","year":2022,"doi":"10.1001/jama.2022.16464"}]},"route":"/people/cheng-ying/","neighbours":{"cancer":[{"id":"extensive-stage-sclc","kind":"cancer","name":"Extensive-stage small-cell lung cancer","route":"/cancers/extensive-stage-sclc/"},{"id":"limited-stage-sclc","kind":"cancer","name":"Limited-stage small-cell lung cancer","route":"/cancers/limited-stage-sclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"adebrelimab","kind":"drug","name":"Adebrelimab","route":"/drugs/adebrelimab/"},{"id":"anlotinib","kind":"drug","name":"Anlotinib","route":"/drugs/anlotinib/"},{"id":"serplulimab","kind":"drug","name":"Serplulimab","route":"/drugs/serplulimab/"}],"institution":[{"id":"jilin-cancer-hospital","kind":"institution","name":"Jilin Cancer Hospital","route":"/institutions/jilin-cancer-hospital/"}],"trial":[{"id":"astrum-005","kind":"trial","name":"ASTRUM-005","route":"/trials/astrum-005/"},{"id":"capstone-1","kind":"trial","name":"CAPSTONE-1","route":"/trials/capstone-1/"}]}}